News Detail
New Delhi, 17 Oct 2024: Cipla and Alkem Laboratories have emerged as the leading contenders to acquire a controlling stake in Mumbai-based Sahajanand Medical Technologies (SMT), India’s largest cardiac stent manufacturer. This comes after private equity giants KKR, TPG Capi......
View Details
Source : Business Standard
cipla
alkem laboratories
sahajanand medical technologies
SMT acquisition
cardiac stent manufacturer
KKR
TPG Capital
Apax Partners
kotadia family
morgan stanley private equity asia
samara capital
kotak pre-IPO opportunities fund
private equity
IPO plans
Rs 3
500 crore
Rs 4
000 crore
medical device industry
stent market in India
drug-eluting stent
DES market
Abbott Vascular
Boston Scientific
Medtronic
translumina
Meril Life Sciences
coronary stent market
expanding Europe presence
FY24
Related News
- Court awards Rs. 10 lakhs as damages to Jan Aushadhi in trademark battle (17-10-2024)
- TN Siddha Medical Council Members not Permitted to Store Allopathy Medicine Without License: Madras HC (17-10-2024)
- Amritsar: Pregabalin, Gabapentin intoxicants worth Rs 14.80L seized in Katra Sher Singh (17-10-2024)
- Health worker arrested for mixing TB patient’s sputum in doctor’s food (17-10-2024)
- DoP directs NPPA to recalculate ceiling prices of three antibiotics based on Cipla's applications (17-10-2024)
- CSIR-NIIST to establish centres of excellence in Ayurveda, performance chemicals (17-10-2024)
- India, Uzbekistan discuss ways to ensure quality, safety in pharma sector (17-10-2024)
- Woman accused arrested with 127 pieces of cough syrup (16-10-2024)
- Raid on unlicensed medical store in Sakchi: Large stock of banned medicines found (16-10-2024)
- Mitskind Healthcare gifts 15 cars to employees ahead of Diwali (16-10-2024)